Anti-PD-L2 antibody [CAL28] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal PD-L2 antibody. Carrier free. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CD273, B7DC, PDCD1L2, PDL2, PDCD1LG2, Programmed cell death 1 ligand 2, PD-1 ligand 2, PD-L2, PDCD1 ligand 2, Programmed death ligand 2, Butyrophilin B7-DC, B7-DC
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PD-L2 antibody [CAL28] - BSA and Azide free (AB261838)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol-permeabilized HDLM-2 (human Hodgkin lymphoma) cells labeling PD-L2 with ab256386 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG Isotype control (ab172730) (Black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor®488) (ab150077), at 1/2000 dilution was used as the secondary antibody.
This data was developed using the same antibody clone in a different buffer formulation containing PBS and sodium azide (ab256386).
- IP
Supplier Data
Immunoprecipitation - Anti-PD-L2 antibody [CAL28] - BSA and Azide free (AB261838)
PD-L2 was immunoprecipitated from 0.35 mg of HDLM-2 (human Hodgkin lymphoma) whole cell lysate with ab256386 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab256386X at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
This data was developed using the same antibody clone in a different buffer formulation containing PBS and sodium azide (ab256386).
All lanes:
Immunoprecipitation - Anti-PD-L2 antibody [CAL28] (<a href='/en-us/products/primary-antibodies/pd-l2-antibody-cal28-ab256386'>ab256386</a>)
Predicted band size: 31 kDa
Observed band size: 45-60 kDa
false
Related conjugates and formulations (8)
-
Anti-PD-L2 antibody [CAL28]
-
578 PE
PE Anti-PD-L2 antibody [CAL28]
-
660 APC
APC Anti-PD-L2 antibody [CAL28]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-PD-L2 antibody [CAL28]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PD-L2 antibody [CAL28]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-PD-L2 antibody [CAL28]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-PD-L2 antibody [CAL28]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-PD-L2 antibody [CAL28]
Reactivity data
Product details
ab261838 is the carrier-free version of ab256386.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PD-L2 offers protection to tissues from autoimmunity by regulating T-cell activation and fostering tolerance. By engaging with its receptor PD-1 PD-L2 forms a complex that modulates the immune response to prevent overactivation. This interaction limits the immune system's potential damage to healthy tissues maintaining proper immune function in diverse environments.
Pathways
PD-L2 participates in the immune checkpoint pathways where it works closely with PD-1 to mediate immune responses. PD-L2 forms an important part of the program death-1 (PD-1) pathway which plays a prominent role in downregulating T-cell activity. It relates to proteins such as PD-L1 which also interacts with PD-1 modulating immune tolerance and response to infections or tumors.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
World journal of gastrointestinal oncology 17:102417 PubMed40487970
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com